Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
GlaxoSmithKline PLC
NYSE:GSK
GlaxoSmithKline PLC
NYSE:GSK
Price:
47.28
USD
-1.85%
Market Closed
Market Cap:
$96.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
GlaxoSmithKline PLC
NYSE:GSK
|
UK |
|
Tenaris SA
MIL:TEN
|
LU |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BOY
|
ES |
|
T
|
TriMas Corp
F:MQ1
|
US |
|
R
|
Revvity Inc
XMUN:PKN
|
US |
|
Essity AB (publ)
STO:ESSITY A
|
SE |
|
A
|
American Express Co
XHAM:AEC1
|
US |
|
M
|
Man Wah Holdings Ltd
SWB:AAM
|
HK |
|
I
|
Inspur International Ltd
HKEX:596
|
HK |
|
Avnet Inc
NASDAQ:AVT
|
US |
|
Isetan Mitsukoshi Holdings Ltd
TSE:3099
|
JP |
|
L
|
Liberty Global PLC
NASDAQ:LBTYB
|
UK |
|
N
|
North American Construction Group Ltd
F:N5Z
|
CA |
|
Controladora Vuela Compania de Aviacion SAB de CV
OTC:CTTRF
|
MX |
|
Enablence Technologies Inc
XTSX:ENA
|
CA |
|
B
|
Bid Corporation Ltd
JSE:BID
|
ZA |
|
Lynas Rare Earths Ltd
OTC:LYSCF
|
MY |
|
Kuala Lumpur Kepong Bhd
OTC:KLKBF
|
MY |
|
N
|
National Bank of Canada
OTC:NTIOF
|
CA |
|
C
|
China Shenhua Energy Co Ltd
XMUN:IKF
|
CN |
|
Ambev SA
BOVESPA:ABEV3
|
BR |
|
Washington H. Soul Pattinson and Company Ltd
OTC:WSOUF
|
AU |
|
Sumitomo Corp
TSE:8053
|
JP |
|
W
|
Wells Fargo & Co
DUS:NWT
|
US |
Wall St Price Targets
GSK Price Forecast
Based on 24 analysts
Based on 24 analysts
+17% Upside
from
$47.28
today
GlaxoSmithKline PLC (GSK)’s 12-month stock price forecast through October 2027 has a consensus target of $55.46, implying 17% upside. The forecast is based on price targets from 24 Wall Street analysts.
GSK Analyst Rating
Based on 8 analysts
Based on 8 analysts
Analysts rate GSK Hold, with 5 of 8 recommending Hold.
GlaxoSmithKline PLC Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GSK's stock price target?
Price Target
55.46
USD
55.46
USD
According to Wall Street analysts, the average 1-year price target for GSK is 55.46 USD with a low forecast of 39.95 USD and a high forecast of 85.92 USD.
What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 4%.
What is the Pre-Tax Income forecast for GlaxoSmithKline PLC?
Projected CAGR
13%
13%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 13%.
What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 6%.